Skip to site alert.
Skip to content
Join us for the HICCC's 50th Anniversary Symposium on Thursday, September 15.
Our dedicated access representatives can help you make an appointment today.
We work with our communities and patients to remove access barriers to cancer prevention, screening, treatment and survivorship services.
Learn about the research being pursued by members of the Herbert Irving Comprehensive Cancer Center.
We're dedicated to developing the next generation of researchers and physicians through cross-disciplinary training and fellowship programs
Showing 61 - 70 of 240 results.
Explore the HICCC's Annual Report
The new Center will build upon the dedicated MDS program at Columbia University, a longstanding program of excellence that has served as a national leader in MDS research.
The Office of Community Outreach and Engagement at the HICCC has been awarded a new three-year grant supporting work on skin cancer risk reduction and HPV vaccination education in Staten Island.
Researchers from the Herbert Irving Comprehensive Cancer Center presented new research on breast cancer risk prediction at the 2021 San Antonio Breast Cancer Symposium.
A new study from Alexander Melamed, MD, MPH, is shining a spotlight on the massive disparities we see in rates of cervical cancer across different areas of NYC.
Ryan Moy, MD, PhD, and Sam Yoon, MD, share insights on stomach cancer, including recent surgical advances and what the future holds for stomach cancer research and treatment.
Steven Reiner, MD, Alison Taylor, PhD, and Timothy Wang, MD, have recently won V Foundation awards for their cutting-edge cancer research in genetics, immunotherapy, and gastric cancers.
Congratulations to HICCC members named as 2021 Highly Cited Researchers--researchers who produced multiple papers ranking in the top 1% globally by citations for their field and year of publication.
Awarded a new NIH grant, Dr. Chin Hur is conducting comparative modeling aimed at improving the prevention and detection of stomach cancer and having an impact on cancer control policy in the U.S.
Sharon Howell had an encouraging response as a patient in the I-SPY clinical trials, and the outcome could also translate to a lower likelihood of her cancer coming back in the future.